A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.
暂无分享，去创建一个
L. weiswald | A. Leary | E. Kalbacher | A. Floquet | P. Follana | B. Clarisse | F. Joly | L. Poulain | J. Lequesne | L. Gladieff | M. Fabbro | C. Gavoille | J. Medioni | B. You | F. Giffard | J. Frenel | A. Leconte | M. Briand | P. Just | P. Brachet | S. Abadie-Lacourtoisie | A. Lesoin | C. Blanc‐Fournier